View All Existing Legislation for State and Federal Transparency Reporting
To view legislation specific to a state, please use the navigation buttons below. Click on a state to view only that state’s legislation.
Transparency Reports and Reporting of Physician Ownership or Investment Interests 
Sec. 1128G. [42 U.S.C. 1320a-7h] (a) Transparency Reports.
This legislation specifies what information manufacturers must include in their reports. This legislation covers “payments or other transfers of value.”
AB 128, Statutes of Nevada Chapter 409 (effective October 1, 2007) requires that all wholesalers or manufacturers who employ a person to sell or market a drug, medicine, chemical, device, or appliance in Nevada must comply with certain requirements regarding their marketing practices. On January 30, 2008, regulations promulgated by the Nevada State Board of Pharmacy to implement AB 128 became effective.
AN ACT CONCERNING REPORTING OF PAYMENTS BY MANUFACTURERS TO INDEPENDENTLY-PRACTICING ADVANCED PRACTICE REGISTERED NURSES.
Not later than July 1,  2017, and [quarterly] annually thereafter, an applicable manufacturer that provides a payment or other transfer of value to an advanced practice registered nurse, who is practicing not in collaboration with a physician in the state, in accordance with subsection (b) of section 20-87a, as amended by this act, shall submit to the Commissioner of Consumer Protection, in the form and manner prescribed by the commissioner, the information described in 42 USC 1320a-7h, as amended from time to time, for the preceding calendar year.
HEALTH AND SAFETY CODE SECTION 119400-119402
Every pharmaceutical company shall adopt a Comprehensive Compliance Program that is in accordance with the April
2003 publication “Compliance Program Guidance for Pharmaceutical Manufacturers,” which was developed by the United States Department of Health and Human Services Office of Inspector General (OIG).
Prescription Drug Advertising Expense Reporting
Governor’s Office of Health Enhancement and Lifestyle Planning (GOHELP) – Series 1
This rule establishes advertising expense disclosure requirements for all manufacturers and labelers of prescription drugs dispensed in this state who employ, direct or utilize marketing representatives.
§16-29H-8. Continuing efforts to reduce prescription drug prices
WEST VIRGINIA CODE: Chapter 16. Public Health
Article 29H. Interagency Health Council
This legislation details the reporting requirements to which pharmaceutical companies must adhere, specifically spend reporting related to advertising, marketing, and promotional costs.
151.461 Gifts to Practitioners Prohibited
It is unlawful for any manufacturer or wholesale drug distributor, or any agent thereof, to offer or give any gift of value to a practitioner. A medical device manufacturer that distributes drugs as an incidental part of its device business shall not be considered a manufacturer, a wholesale drug distributor, or agent under this section.
151.47 Wholesale Drug Distributor Licensing Requirements
This legislation details the licensing requirements and policies for wholesale drug distributors.
Chapter 8A – Access to Prescription Drugs
§48-833 Subchapter III – Full Disclosure of Prescription Drug Marketing Costs
This legislation details the requirements that manufacturers and labelers of prescription drugs must follow to disclose prescription drug marketing costs properly. This legislation goes into depth about the manner of reporting, the content of annual reports, department reports, confidentiality, and penalties.